Vor Biopharma Inc at B Riley Oncology Conference (Virtual) Transcript
Thank you all for joining us this morning at the B. Riley Oncology Investor Conference. My name is Justin Walsh. I'm an oncology-focused analyst on the B. Riley healthcare team. I'm here hosting the fireside chat with Vor Biopharma. I'd like to remind the audience that you're welcome to submit questions on the platform at any time. While we may not get to every question, we'll do our best to address as many as possible towards the end of the fireside chat
To kick things off, can you introduce yourself and your role at Vor?
Hi, Justin. Thank you very much for having us. My name is Robert Ang. I'm privileged to be President and CEO of Vor Bio.
Questions & Answers
Perfect. So, let's start the conversation by discussing the broad clinical challenge that the company is seeking to address with its technology.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
